Results 161 to 170 of about 304,767 (203)
Some of the next articles are maybe not open access.
Risk of occult atypical hyperplasia or cancer in women with non-atypical endometrial hyperplasia
Gynecologic Oncology, 2020AbstractAimThe aim of this study was to identify subsets of patients diagnosed with nonatypical endometrial hyperplasia (NAEH) by endometrial biopsy who had high risk for occult atypical endometrial hyperplasia (AEH) or endometrial cancer (EC).MethodsWe retrospectively reviewed the medical records of 281 patients who underwent hysterectomy within 6 ...
N. Lee +10 more
openaire +3 more sources
Endometrial Lesions in Uteri Resected for Atypical Endometrial Hyperplasia
American Journal of Clinical Pathology, 1978Resected uteri from a series of 48 consecutive patients with atypical endometrial hyperplasia ("carcinoma in situ") identified in curettings were studied to determine the frequency of associated adenocarcinoma. Thirty-nine of the women had received estrogen or oral contraceptives.
F, Tavassoli, F T, Kraus
openaire +2 more sources
Fertility and Sterility, 2003 OBJECTIVE: To evaluate whether an alternative treatment to radical hysterectomy exists for young women with endometrial adenocarcinoma. DESIGN: A review of the literature (70 articles) plus personal results. SETTING: University hospital.
exaly +2 more sources
Human Pathology, 1989
The DNA content and nuclear measurements of five groups of endometrial proliferations--proliferative endometrium (PE), simple hyperplasia (SH), atypical hyperplasia (AH), well-differentiated carcinoma (WDC), and poorly differentiated carcinoma (PDC)--were compared using 14 descriptors in a stepwise discriminant analysis.
H J, Norris, R L, Becker, U V, Mikel
openaire +2 more sources
The DNA content and nuclear measurements of five groups of endometrial proliferations--proliferative endometrium (PE), simple hyperplasia (SH), atypical hyperplasia (AH), well-differentiated carcinoma (WDC), and poorly differentiated carcinoma (PDC)--were compared using 14 descriptors in a stepwise discriminant analysis.
H J, Norris, R L, Becker, U V, Mikel
openaire +2 more sources
Atypical Endometrial Hyperplasia: Grounds for Possible Misdiagnosis of Endometrial Adenocarcinoma
Gynecologic and Obstetric Investigation, 2003<i>Objective:</i> The diagnoses of atypical hyperplasia and well-differentiated adenocarcinoma imply totally different approaches because of clinical and patient-oriented ramifications, especially when morphological differences are not entirely conclusive.
Pedro, Valenzuela +2 more
openaire +2 more sources
Atypical endometrial hyperplasia: A tough call
International Journal of Gynecological Cancer, 2005Most gynecologists determine therapy based on current World Health Organization (WHO) classification of endometrial hyperplasia. Endometrioid neoplastic lesions of the endometrium are thought to follow a continuum of histologically distinguishable lesions ranging from endometrial hyperplasia without atypia, to endometrial hyperplasia with atypia (AEH),
openaire +1 more source
Atypical Endometrial Hyperplasia, Low-grade
American Journal of Surgical Pathology, 2021Atypical endometrial hyperplasia (AEH) is considered a precursor of endometrioid carcinoma. The 2020 World Health Organization (WHO) classification divides endometrial hyperplasia into 2 categories: hyperplasia without atypia and atypical hyperplasia/endometrioid intraepithelial neoplasia (EIN); however, this classification does not consider the degree
D'Angelo, Emanuela +5 more
openaire +4 more sources
The American Journal of Surgical Pathology, 1998
Many studies have attempted to identify histologic features that aid in the distinction of atypical hyperplasia (AH) from hyperplasia without atypia and well-differentiated endometrioid carcinoma, but few have evaluated the reproducibility of these diagnoses. Five pathologists independently reviewed 100 endometrial biopsy and curettage specimens chosen
B S, Kendall +6 more
openaire +2 more sources
Many studies have attempted to identify histologic features that aid in the distinction of atypical hyperplasia (AH) from hyperplasia without atypia and well-differentiated endometrioid carcinoma, but few have evaluated the reproducibility of these diagnoses. Five pathologists independently reviewed 100 endometrial biopsy and curettage specimens chosen
B S, Kendall +6 more
openaire +2 more sources
Applied Immunohistochemistry & Molecular Morphology, 2006
The facilitative transport of monosaccharides in human cells is accomplished by a family of transmembrane proteins, GLUT-1 to GLUT-7, that differ in their tissue distribution, affinities for specific monosaccharides, and physiologic regulation. GLUT-1, a high-affinity glucose transporter, is normally expressed in erythrocytes, the perineurium of ...
Amanda, Ashton-Sager +2 more
openaire +2 more sources
The facilitative transport of monosaccharides in human cells is accomplished by a family of transmembrane proteins, GLUT-1 to GLUT-7, that differ in their tissue distribution, affinities for specific monosaccharides, and physiologic regulation. GLUT-1, a high-affinity glucose transporter, is normally expressed in erythrocytes, the perineurium of ...
Amanda, Ashton-Sager +2 more
openaire +2 more sources
DNA Replication Error in Endometrial Carcinoma and Complex Atypical Endometrial Hyperplasia
Cancer Genetics and Cytogenetics, 1999We attempted to define the relation between DNA replication errors (RERs) in endometrial carcinomas and the precancerous lesion complex atypical endometrial hyperplasia (ATH) and clinicopathological characteristics. Tissue samples from 93 patients with endometrial carcinoma diagnosed as endometrioid adenocarcinoma and 26 patients with ATH (including 21
M, Ohwada +4 more
openaire +2 more sources